Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBAI20 Vaccine in Hepatitis B Non-responders
NCT03415672Phase 2Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Oct 2017
- Primary completion
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of HBAI20 in hepatitis B (HBV), sponsored by Maastricht University Medical Center+. Started Oct 2017; status: completed.
02
Drugs
HBAI20
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT03415672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03415672.